surpass 4 tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial surpass-2 tirzepatide vs semaglutide results

This mimics the effects of the hormone amylin and can also slow down stomach emptying, decrease glucagon secretion after meals, and control appetite

Common Side Effects The most common side effects of compounded tirzepatide include: Nausea Diarrhea Vomiting Constipation Abdominal pain Indigestion Injection site reactions Fatigue Allergic reactions Belching Hair loss Heartburn This is not a complete list of possible side effects

Wegovy supports appetite control via GLP-1, but metabolism naturally adjusts during weight reduction

Although current evidence does not demonstrate a strong causal link, clinical judgment still matters